Australian Government: Australian Institute of Health and Welfare METeOR Home Page

Person with cancer—comorbidities, Colinet defined comorbidities code N[N]

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termColinet comorbidities
METeOR identifier:Help on this term432994
Registration status:Help on this termHealth, Standard 08/05/2014
Definition:Help on this termDiseases or conditions present at diagnosis and defined as comorbidities relevant to non-small cell lung cancer by Colinet et al 2005, as represented by a code.
Data Element Concept:Person with cancer—comorbidities

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termNumber
Format:Help on this termN[N]
Maximum character length:Help on this term2
Permissible values:Help on this term
ValueMeaning
1Cardiovascular
2Respiratory
3Neoplastic
4Renal insufficiency
5Diabetes
6Alcoholism
7Tobacco consumption
Supplementary values:Help on this term
97Not applicable-no comorbidities present
98Unknown whether comorbidities are present
99Comorbidities are present but type not stated/inadequately described

Collection and usage attributes

Guide for use:Help on this term

Record each comorbid condition, as defined by the Colinet criteria, present in the patient at the time of diagnosis for lung cancer.

The criteria were developed specifically for non-small cell lung cancer where comorbidities may be an important variable in treatment decisions and prognosis, however, record each comorbid condition for all lung cancers.

Colinet criteria for comorbidities

CODE 1   Cardiovascular

Defined as the presence of one or more of the following:

  • congestive heart failure,
  • ischaemic cardiopathy with/without myocardial infarction,
  • severe valvular cardiopathy,
  • arrhythmia requiring chronic treatment,
  • history of cerebrovascular disease,
  • hypertension, and/or
  • peripheral vascular disease

CODE 2   Respiratory

Defined as the presence of one or more of the following:

  • history of tuberculosis,
  • history of pleural effusion or pneumonia,
  • asthma,
  • pulmonary embolism,
  • chronic pulmonary insufficiency (as defined by a chronic hypoxemia less than 60 mmHg, and/or
  • chronic obstructive pulmonary disease (COPD) inducing a FEV1 less than 1.5l)

CODE 3   Neoplastic

Defined as a previous personal history of cancer excluding basal cell carcinoma of the skin and in situ carcinoma of the cervix.

CODE 4   Renal insufficiency

Defined as a creatinine clearance lower than 60 ml/min­.

CODE 5   Diabetes mellitus

Defined as diabetes treated with either oral hypoglycaemics or insulin.

CODE 6   Alcoholism

Defined as a daily consumption of:

  • more than 80g of alcohol (8 standard drinks) for men
  • more than 40g of alcohol (4 standard drinks) for women

CODE 7   Tobacco consumption

Defined as a lifelong consumption of an equivalent of at least 100 cigarettes.

Comments:Help on this term

The Colinet system provides criteria to define comorbidities and a scoring system whereby each comorbidity is weighted and assigned a score, then scores are added to provide the Simplified Comorbidity Score (SCS). For instance, Colinet et al. 2005 found that an SCS greater than 9 was found to be an independent prognostic factor of poor outcome in NSCLC (non-small-cell lung cancer).

For the purpose of this data item, record each comorbidity as defined by the Colinet criteria but do not score them.

Source and reference attributes

Submitting organisation:Help on this termCancer Australia
Reference documents:Help on this termColinet, B; Jacot, W et al 2005. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson’s index. British Journal of Cancer 93:1098-1105

Data element attributes

Collection and usage attributes

Collection methods:Help on this termThis information should be sought from the patient's medical record.
Comments:Help on this term

Comorbidities may influence treatment decisions and patient outcomes; they may be used to adjust outcome statistics when evaluating patient survival and other outcomes.

Comorbidities are generally used with cancer patients to refer to conditions not related to the cancer, and in epidemiology to indicate the coexistence of two or more disease processes.

The presence of comorbidities in a patient may affect treatment decisions and be an important prognostic determinant. For example, they may be used to adjust outcome statistics when evaluating patient survival and other outcomes.

Source and reference attributes

Submitting organisation:Help on this termCancer Australia
Reference documents:Help on this termColinet, B; Jacot, W et al 2005. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson’s index. British Journal of Cancer 93:1098-1105

Relational attributes

Implementation in Data Set Specifications:Help on this term

Adolescent and young adult cancer (clinical) DSS Health, Superseded 14/05/2015

Adolescent and young adult cancer (clinical) NBPDS Health, Standard 14/05/2015

Lung cancer (clinical) DSS Health, Superseded 14/05/2015

Lung cancer (clinical) NBPDS Health, Standard 14/05/2015

My items Help on this term
Download Help on this term